NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,284 | -99.9% | 12,608 | 0.0% | 0.64% | +3.1% |
| Q2 2023 | $1,272,273 | +9.7% | 12,608 | 0.0% | 0.62% | +5.1% |
| Q1 2023 | $1,159,936 | +96965.8% | 12,608 | -4.3% | 0.59% | -5.8% |
| Q4 2022 | $1,195 | -99.9% | 13,173 | -4.9% | 0.62% | +9.3% |
| Q3 2022 | $1,053,000 | -10.1% | 13,858 | 0.0% | 0.57% | -7.0% |
| Q2 2022 | $1,171,000 | -5.9% | 13,858 | -2.3% | 0.61% | +9.3% |
| Q1 2022 | $1,245,000 | +7.8% | 14,185 | +7.5% | 0.56% | +32.2% |
| Q4 2021 | $1,155,000 | -3.5% | 13,200 | -9.8% | 0.42% | -8.4% |
| Q3 2021 | $1,197,000 | -11.2% | 14,640 | -0.9% | 0.46% | -12.6% |
| Q2 2021 | $1,348,000 | -7.9% | 14,775 | -13.7% | 0.53% | -15.0% |
| Q1 2021 | $1,463,000 | -8.8% | 17,115 | +0.7% | 0.62% | -16.2% |
| Q4 2020 | $1,605,000 | +10.4% | 16,995 | +1.7% | 0.75% | -6.8% |
| Q3 2020 | $1,454,000 | -2.4% | 16,715 | -1.9% | 0.80% | -5.7% |
| Q2 2020 | $1,489,000 | +6.7% | 17,045 | +0.7% | 0.85% | -11.2% |
| Q1 2020 | $1,395,000 | -13.0% | 16,925 | -0.1% | 0.96% | +5.9% |
| Q4 2019 | $1,604,000 | +4.2% | 16,940 | -4.3% | 0.90% | -0.4% |
| Q3 2019 | $1,539,000 | -2.3% | 17,705 | +2.6% | 0.91% | -3.8% |
| Q2 2019 | $1,576,000 | -1.1% | 17,255 | +4.2% | 0.94% | -5.4% |
| Q1 2019 | $1,593,000 | -99.9% | 16,565 | -0.2% | 1.00% | -1.5% |
| Q4 2018 | $1,424,875,000 | -0.4% | 16,605 | 0.0% | 1.01% | +22.2% |
| Q3 2018 | $1,430,687,000 | +16.3% | 16,605 | +2.0% | 0.83% | +10.4% |
| Q2 2018 | $1,229,791,000 | -4.4% | 16,280 | +2.3% | 0.75% | -1.8% |
| Q1 2018 | $1,286,324,000 | -3.4% | 15,910 | +0.3% | 0.76% | -6.6% |
| Q4 2017 | $1,331,606,000 | +2.1% | 15,860 | +4.4% | 0.82% | +5.6% |
| Q3 2017 | $1,304,491,000 | +4.0% | 15,195 | +1.1% | 0.77% | +1.7% |
| Q2 2017 | $1,254,554,000 | +16.7% | 15,030 | +3.9% | 0.76% | +15.0% |
| Q1 2017 | $1,074,687,000 | +1.8% | 14,470 | -0.2% | 0.66% | -6.5% |
| Q4 2016 | $1,056,180,000 | -9.8% | 14,500 | -2.2% | 0.71% | -12.2% |
| Q3 2016 | $1,170,582,000 | -29.5% | 14,825 | -26.3% | 0.81% | -32.8% |
| Q2 2016 | $1,660,514,000 | +15.0% | 20,125 | +1.0% | 1.20% | +7.9% |
| Q1 2016 | $1,443,729,000 | -17.7% | 19,930 | -2.3% | 1.11% | -18.4% |
| Q4 2015 | $1,754,356,000 | +0.4% | 20,390 | +7.3% | 1.36% | -3.4% |
| Q3 2015 | $1,746,940,000 | -6.9% | 19,005 | -0.4% | 1.41% | +0.9% |
| Q2 2015 | $1,876,819,000 | -4.1% | 19,085 | -3.9% | 1.40% | -2.6% |
| Q1 2015 | $1,957,409,000 | +3.0% | 19,850 | -3.2% | 1.44% | +3.8% |
| Q4 2014 | $1,900,920,000 | -0.8% | 20,515 | +0.8% | 1.38% | -3.7% |
| Q3 2014 | $1,915,546,000 | +0.5% | 20,350 | -3.4% | 1.44% | +3.8% |
| Q2 2014 | $1,906,562,000 | +4.4% | 21,060 | -2.0% | 1.38% | +3.1% |
| Q1 2014 | $1,826,655,000 | +5.6% | 21,485 | -0.2% | 1.34% | +5.0% |
| Q4 2013 | $1,730,180,000 | +4.6% | 21,525 | -0.2% | 1.28% | -1.5% |
| Q3 2013 | $1,654,251,000 | +11.9% | 21,565 | +3.1% | 1.30% | +5.0% |
| Q2 2013 | $1,478,900,000 | – | 20,915 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |